3H Health Investment
Venture capitalShanghai · Series A–Late Stage
Find your way into 3H Health Investment
Sign up to see every warm intro you have to 3H Health Investment
- Paths you didn't know you had: your email and LinkedIn already hold routes to the 3H Health Investment team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
3H Health Investment (Sanzheng Health Investment) is a Chinese healthcare-focused investment firm that partners with entrepreneurs to build leading companies in niche industry segments.
Source: firm website, verified Aug 3, 2026.
What they invest in
from 3 of 3 portfolio companiesBiotech ×3Healthtech ×3Deep Tech ×2AI & Machine Learning ×1Digital Health ×1Medical Devices ×1
HQs:China×2
Investments · 3 tracked
founders shown can be your intro pathBy year:2022 · 12021 · 23 dated
An innovative biopharmaceutical company focused on developing therapies for chronic kidney disease across multiple clinical stages, with a pipeline of eight products covering conditions such as hyperphosphatemia, renal anemia, IgA nephropathy, and diabetic kidney disease.
BiotechDigital HealthHealthtechMedical DevicesShanghai, CN
Co-investorsLAVLilly Asia VenturesQuan Capital3E Bioventures CapitalSherpa Healthcare PartnersYuanBio Venture Capital
EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform.
BiotechDeep TechHealthtech
Co-investorsLAVLilly Asia VenturesWI Harper GroupAlwin CapitalBioTrack CapitalIDG Capital+2 more
Therorna develops circular RNA-based therapeutic candidates and preventive medicines for diseases with unmet clinical needs.
AI & Machine LearningBiotechDeep TechHealthtechBeijing, CN
Co-investorsCenova CapitalQuan CapitalMSA CapitalSherpa Healthcare Partners
Frequently asked questions
- What stage does 3H Health Investment invest at?
- 3H Health Investment invests at the Series A, Series B, Series C, Late Stage stages.
- What sectors does 3H Health Investment focus on?
- 3H Health Investment focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is 3H Health Investment located?
- 3H Health Investment is headquartered in Shanghai, CN.
Similar investors
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
GV (Google Ventures) is a venture capital firm that has invested in AI and machine learning since its early days, backing more than 100 AI companies across infrastructure, life sciences, and applications.
Menlo Ventures is an early-stage venture capital firm backing transformative technology companies, with a strong current emphasis on artificial intelligence across enterprise, healthcare, and consumer markets.
Norwest is a venture capital and growth equity investment firm that has backed over 700 companies across technology, consumer, and healthcare over its 65-year history.
Sofinnova is an investment firm focused on the life sciences and biotechnology sector, partnering with companies from inception through drug development, regulatory approval, company building, and IPO.






.jpeg)
